Lobe Sciences Ltd
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The … Read more
Lobe Sciences Ltd (LOBEF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: -0.154x
Based on the latest financial reports, Lobe Sciences Ltd (LOBEF) has a cash flow conversion efficiency ratio of -0.154x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-579.01K) by net assets ($3.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lobe Sciences Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Lobe Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lobe Sciences Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lobe Sciences Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TUGA Innovations Inc
PINK:TUGAF
|
0.025x |
|
Aviv Arlon Ltd
TA:AVLN
|
-0.017x |
|
CORDIANT DIGITAL INFR.SUB
F:86L0
|
N/A |
|
Ecofibre Limited
PINK:EOFBF
|
-0.290x |
|
XPPE
F:XPPE
|
N/A |
|
RHEPA
PINK:RHEPA
|
-0.571x |
|
LN Future Invest AB (publ)
ST:LNFI
|
N/A |
|
FRESNILLO
BE:FNL
|
N/A |
Annual Cash Flow Conversion Efficiency for Lobe Sciences Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Lobe Sciences Ltd from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-08-31 | $4.89 Million | $-1.42 Million | -0.290x | -295.23% |
| 2024-08-31 | $-3.11 Million | $-462.29K | 0.148x | -98.62% |
| 2023-08-31 | $-160.13K | $-1.72 Million | 10.733x | +275.18% |
| 2022-08-31 | $445.69K | $-2.73 Million | -6.127x | -1273.60% |
| 2021-08-31 | $11.29 Million | $-5.04 Million | -0.446x | -340.57% |
| 2020-08-31 | $12.07 Million | $-1.22 Million | -0.101x | +69.32% |
| 2019-08-31 | $6.19 Million | $-2.04 Million | -0.330x | -102.05% |
| 2018-08-31 | $-124.64K | $-2.01 Million | 16.100x | +833.14% |
| 2017-08-31 | $23.65K | $-51.93K | -2.196x | -- |